Related Experiment Video

Updated: Jun 8, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Role of the mTOR pathway in normal and tumoral adrenal cells

M C De Martino1, P M van Koetsveld, R Pivonello

  • 1Department of Internal Medicine, Division of Endocrinology, Erasmus MC, Rotterdam, The Netherlands. demartino.mc@gmail.com

Neuroendocrinology
|September 11, 2010
PubMed

Insights

The mammalian target of rapamycin (mTOR) pathway is implicated in adrenal tumors like adrenocortical carcinomas and pheochromocytomas. mTOR inhibitors may offer new therapeutic options for these aggressive cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • The mammalian target of rapamycin (mTOR) pathway is a key regulator in cellular processes and is frequently dysregulated in various human cancers.
  • Growth factors and their receptors, implicated in adrenal tumor development, often signal through the PI3K/AKT/mTOR pathway.
  • Dysregulation of AKT signaling has been observed in aggressive adrenal tumors such as adrenocortical carcinomas and pheochromocytomas.

Purpose of the Study:

  • To investigate the potential role of the mTOR pathway in the pathogenesis of normal and pathological adrenal gland tissues.
  • To explore the therapeutic potential of mTOR inhibitors in treating malignant adrenal tumors.

Main Methods:

  • This study is based on a review of current scientific literature and existing knowledge regarding the mTOR pathway and adrenal gland tumors.
  • Analysis of signaling pathways involved in adrenal tumorigenesis, focusing on PI3K/AKT/mTOR.
  • Evaluation of the potential of mTOR inhibitors as a therapeutic strategy.

Main Results:

  • The mTOR pathway is a significant intracellular mediator for growth factor receptor activity, including VEGF and IGFs.
  • Evidence suggests that the PI3K/AKT/mTOR pathway is involved in the pathogenesis of adrenal tumors.
  • Dysregulation of AKT has been reported in adrenocortical carcinomas and pheochromocytomas.

Conclusions:

  • The mTOR pathway likely plays a role in the development of both adrenocortical carcinomas and pheochromocytomas.
  • mTOR inhibitors, by targeting mitogenic and angiogenic factors, represent a promising novel therapeutic avenue for managing aggressive adrenal malignancies.

More Related Videos

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions04:33

Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions

Published on: March 12, 2019

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...